This article investigates the relationship of value foundations to the use of drugs. The argument is presented that it is logically impossible to make drug use decisions without evaluating the outcomes of various alternatives and choosing the most highly valued in the circumstances. A map of the major value foundations upon which drug choices might be made is provided, and their relationship to one particular drug category, the anti-anxiety agents or tranquilizers, is explored. The conclusion is reached that a purely therapeutic drug ethic may be problematic as an acceptable basis for drug use.
Get full access to this article
View all access options for this article.
References
1.
BalterMitchellB.1973“An Analysis of Psychotherapeutic Drug Consumption in the United States.”Etiology of Drug AbuseI (April 17): 57–68.
2.
BalterMitchellB.LevineJerome1971“Character and Extent of Psychotherapeutic Drug Usage in the United States.”Excerpta Medica International Congress Series No. 274. Psychiatry (Part I) Proceedings of the V World Congress of Psychiatry. Mexico, D.F. (November 25-December 4): 80–88.
3.
BlackwellBarry1973“Psychotropic Drugs in Use Today: The Role of Diazepam in Medical Practice.”Journal of the American Medical Association225 (September 24): 1637–1641.
4.
CannonWalterB.1932The Wisdom of the Body. New York: W. W. Norton Co., Inc.
5.
EdwardsCharlesC.1974Statement Before the Subcommittee on Health, Senate Committee on Labor and Public Welfare (February 25).
6.
EllulJacques1964The Technological Society. New York: Alfred A. Knopf.
7.
GrofStanislavWalterN. PahnkeLouisE. GoodmanKurlandAlbert1973“Psychedelic Drug Assisted Psychotherapy in Patients With Terminal Cancer.” Part II. In GoldbergIvanK.MalitzSidneyAustinH. Kutscher (eds.), Psychopharmacological Agents for the Terminally Ill and Bereaved. New York: Columbia University Press: 91–133.
8.
KlermanGerald1971“A Reaffirmation of the Efficacy of Psychoactive Drugs.”Journal of Drug Issues1: 312–319.
9.
KlermanGerald1970“Drugs and Social Values.”International Journal of the Addictions5: 312–319.
10.
KlermanGerald1974“Psychotropic Drugs as Therapeutic Agents.”Hastings Center Studies2 (No. 1): 81–93.
11.
KluckhornFlorenceFredL. Strodtbeck1973Variations in Value Orientations. Westport, Ct.: Greenwood Press, Inc.
12.
KurlandAlbertA.GrofStanislavWalterN. PahnkeLouisE. Goodman1973“Psychedelic Drug Assisted Psychoterapy in Patients With Terminal Cancer.” Part I. In GoldbergIvanK.MalitzSidneyAustinH. Kutscher (eds.), Psychopharmacological Agents for the Terminally Ill and Bereaved. New York: Columbia University Press: 86–90.
13.
LennardHenryL.LeonJ. Epstein1970“Hazards Implicit in Prescribing Psychoactive Drugs: Mystification in Drug Use and Models of Drug Action are Reviewed.”Science169 (July 31): 438–441.
14.
LiftonRobertJ.1971“Protean Man.”Archives of General Psychiatry24: 298–304.
15.
ManheimerDeanI.SusanT. DavidsonMitchellB. BalterGlenD. MellingerIraH. CisinHughJ. Parry1973“Popular Attitudes and Beliefs About Tranquilizers.”American Journal of Psychiatry130 (November): 1246–1253.
16.
MullerCharlotte1972“The Overmedicated Society: Forces in the Marketplace for Medical Care.”Science176 (May 5): 488–492.
17.
MumfordLewis1970The Myth of the Machine: The Pentagon of Power. New York: Harcourt, Brace, Jovanovich, Inc.
18.
PahnkeWalterN.1967“LSD and Religious Experience.” In DeBoldRichardC.RussellC. Leaf (eds.), LSD, Man, and Society. Middletown, Ct.: Wesleyan University Press: 71–72.
19.
ParryHughJ.MitchellB.GlenD. MellingerIraH. CisinDeanI. Manheimer1973“National Patterns of Psychotherapeutic Drug Use.”Archives of General Psychiatry28 (June): 769–783.
20.
RieffPhilip1966The Triumph of the Therapeutic. New York: Harper & Row.
21.
SlotkinJ. S.1955–1956. “The Peyote Way.”TomorrowIV (3): 64–70.
22.
VeatchRobertM.1974“Drugs and Competing Drug Ethics.”Hastings Center Studies2 (No. 1): 68–80.
23.
VeatchRobertM.1976Value Freedom in Science and Technology. Missoula, Montana: Scholars Press.
24.
WeberMax1958The Protestant Ethic and the Spirit of Capitalism. New York: Charles Scribner's Sons.